Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine

DOI 10.1038/nm850

Cited by (1,000)

Items 501–600 of 1,000

Preventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants
Ian M. MacDonald, Yves Sauvé, Paul A. Sieving · 2007 · Canadian Journal of Ophthalmology
Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system
Michael F. Salvatore, Greg A. Gerhardt, Robert D. Dayton, Ronald L. Klein, John A. Stanford · 2009 · Experimental Neurology
Gene Therapy for Parkinsons Disease: Progress and Challenges
Qin Chen, Yi He, Keyi Yang · 2005 · Current Gene Therapy
Tetanus toxin fragment C as a vector to enhance delivery of proteins to the CNS
Jonathan W. Francis, Elena Bastia, Christopher C. Matthews, Deborah A. Parks, Michael A. Schwarzschild, Robert H. Brown, Paul S. Fishman · 2004 · Brain Research
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Maamoon Saleh, Milica Marković, Katherine E. Olson, Howard Eliot Gendelman, Rodney Lee Mosley · 2022 · Journal of Parkinson s Disease
Gene-based Therapies in Parkinson’s Disease
Patricia J. Allen, A. Feigin · 2013 · Neurotherapeutics
Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain
Benjamin Saul Bleier, Richie E. Kohman, Rachel E. Feldman, Shreshtha B Ramanlal, Xue Han · 2013 · PLoS ONE
Reversible neurochemical changes mediated by delayed intrastriatal glial cell line‐derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model
Xin Ling Yang, Birgit Mertens, Enni Lehtonen, Linda Vercammen, Olivier Bockstael, Abdelwahed Chtarto, Marc Levivier, Jacques Brotchi, Yvette Madeleine Michotte, Veerle Baekelandt et al. · 2009 · The Journal of Gene Medicine
Convection-Enhanced Delivery for the Treatment of Pediatric Neurologic Disorders
Debbie K. Song, Russell R. Lonser · 2008 · Journal of Child Neurology
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor
Young-Hwan Ahn, Jean‐Charles Bensadoun, Patrick Aebischer, Anne D. Zurn, Åke Seiger, Anders Björklund, Olle Lindvall, Lars U. Wahlberg, Patrik Brundin, Gabriele S. Kaminski Schierle · 2005 · Brain Research Bulletin
GDNF in treatment of Parkinson's disease: response to editorial
Richard D. Penn, Arif Dalvi, John T. Slevin, Byron A. Young, Don Marshall Gash, Greg A. Gerhardt, Michael Hutchinson · 2006 · The Lancet Neurology
Parkinson’s disease: an update on pathogenesis and treatment
Thomas Foltynie, Joshua Kahan · 2013 · Journal of Neurology
Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
Bin Xing, Tao Xin, Lingling Zhao, Randy L. Hunter, Yan Chen, Guoying Bing · 2010 · Journal of Neuroimmunology
A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activity
Wei‐Li Kuan, Emma L. Poole, Michael N. C. Fletcher, Sharon Karniely, Pam Tyers, Mark R. Wills, Roger A. Barker, John H. Sinclair · 2011 · The Journal of Experimental Medicine
Scientific rationale for the development of gene therapy strategies for Parkinson's disease
Tomas Björklund, Deniz Kirik · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
GDNF-induced cerebellar toxicity: A brief review
Matthias Luz, Erich Mohr, H. Christian Fibiger · 2015 · NeuroToxicology
Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic pain
Adalberto Merighi · 2015 · Expert Opinion on Therapeutic Targets
Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
Yulia A. Sidorova, Konstantin Petrovich Volcho, Nariman Faridovich Salakhutdinov · 2018 · Current Neuropharmacology
Levels of glial cell line‐derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson’s disease
Sophie Virachit, Kathryn J. Mathews, Veronica Cottam, Eryn L. Werry, Emilia Galli, Elisabeth Rappou, Päivi Lindholm, Märt Saarma, Glenda Margaret Halliday, Cynthia Shannon Weickert et al. · 2019 · Brain Pathology
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
Philip C. Buttery, Roger A. Barker · 2020 · Neurotherapeutics
Interleukin-1β mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures
Ana Saavedra, Graça Baltazar, Emı́lia P. Duarte · 2006 · Neurobiology of Disease
Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease
B. K. Harvey, A. Mark, Jenny Chou, Geng-Ci Chen, Barry J. Hoffer, Y. Wang · 2004 · Brain Research
Nigral GFRα1 Infusion in Aged Rats Increases Locomotor Activity, Nigral Tyrosine Hydroxylase, and Dopamine Content in Synchronicity
Brandon Scott Pruett, Michael F. Salvatore · 2013 · Molecular Neurobiology
The neurotoxicity of gene vectors and its amelioration by packaging with collagen hollow spheres
Ben Newland, Teresa C. Moloney, Gianluca Fontana, S. Browne, Mohammad Abu-Rub, Eilís Dowd, Abhay S. Pandit · 2012 · Biomaterials
Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality
Michael F. Salvatore · 2024 · International Journal of Molecular Sciences
Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases
Pengxuan Zhao, Tiantian Wu, Yu Tian, Jia Emil You, Xinwu Cui · 2024 · Advanced Drug Delivery Reviews
Glial cell line-derived neurotrophic factor: Characterization of mammalian posttranslational modifications
Elisa Piccinini, Nisse Kalkkinen, Märt Saarma, Pia Runeberg‐Roos · 2012 · Annals of Medicine
GDNF Gene Delivery via a 2-(Dimethylamino)ethyl Methacrylate Based Cyclized Knot Polymer for Neuronal Cell Applications
Ben Newland, Mohammad Abu-Rub, Michelle Naughton, Yu Zheng, A. V. Pinoncely, Estelle C. Collin, Eilís Dowd, Wenxin Wang, Abhay S. Pandit · 2013 · ACS Chemical Neuroscience
Protecting axons in multiple sclerosis
Alastair Wilkins, Neil J. Scolding · 2008 · Multiple Sclerosis Journal
Regenerative medicine for neurological diseases—will regenerative neurosurgery deliver?
Terry C. Burns, Alfredo Quiñones‐Hinojosa · 2021 · BMJ
Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys
Zhenhua Ren, Jiayin Wang, Shuyan Wang, Chunlin Zou, Xiaobo Li, Yunqian Guan, Zhiguo Chen, Y.Alex Zhang · 2013 · Scientific Reports
Persephin signaling through GFRα1: The potential for the treatment of Parkinson's disease
Yulia A. Sidorova, Kert Mätlik, Павельев Михаил Николаевич, Maria Lindahl, Elisa Piranen, Jeffrey Milbrandt, Urmas Arumäe, Märt Saarma, Maxim M. Bespalov · 2010 · Molecular and Cellular Neuroscience
Nerve growth factor gene delivery: Animal models to clinical trials
Mark H. Tuszynski · 2007 · Developmental Neurobiology
Recent failures of new potential symptomatic treatments for parkinson's disease: Causes and solutions
Gurutz Linazasoro · 2004 · Movement Disorders
Glial Cell Line–Derived Neurotrophic Factor Gene Transfer Exerts Protective Effect on Axons in Sciatic Nerve Following Constriction-Induced Peripheral Nerve Injury
Jhih-Yin Shi, Guei‐Sheung Liu, Li-Feng Liu, Shiao-Mei Kuo, Cha-Hwa Ton, Zhi‐Hong Wen, Richard Tee, Chih‐Hao Chen, Hung‐Tu Huang, Chun-Lin Chen et al. · 2010 · Human Gene Therapy
Viral vector delivery of neurotrophic factors for Parkinson's disease therapy
Martin J. Kelly, Gerard W. O’Keeffe, Aideen M. Sullivan · 2015 · Expert Reviews in Molecular Medicine
Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model
Neil U. Barua, Alison S. Bienemann, Shirley A. Hesketh, Marcella J. Wyatt, Emma S. Castrique, Seth Love, Steven S. Gill · 2012 · Fluids and Barriers of the CNS
Do alpha-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?
Hanna S. Lindgren, Mariah J. Lelos, Stephen B. Dunnett · 2012 · Experimental Neurology
Non-human primate models of PD to test novel therapies
Marc Morissette, Thérèse Di Paolo · 2017 · Journal of Neural Transmission
Multifunctional Neural Interfaces for Closed‐Loop Control of Neural Activity
Christopher A. R. Chapman, Noah Goshi, Erkin Şeker · 2017 · Advanced Functional Materials
Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome
Craig G. van Horne, Jorge E. Quintero, John T. Slevin, Amelia Jane Anderson-Mooney, Julie A. Gurwell, Andrew S. Welleford, John R. Lamm, Renee P. Wagner, Greg A. Gerhardt · 2018 · Journal of neurosurgery
Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures
Fillipe Mendes de Araújo, Rafael Short Ferreira, Cleide Dos Santos Souza, Cleonice Creusa dos Santos, Tácio L.R.S. Rodrigues, Juliana Helena Castro e Silva, Juciano Gasparotto, Daniel Pens Gelain, Ramon dos Santos El-Bachá, Maria de Fátima Dias Costa et al. · 2018 · NeuroToxicology
Gene therapy for Parkinson’s disease: contemporary practice and emerging concepts
Aristide Merola, Amber D. Van Laar, Russell R. Lonser, Krzysztof S. Bankiewicz · 2020 · Expert Review of Neurotherapeutics
RNA Sequencing of Human Peripheral Nerve in Response to Injury: Distinctive Analysis of the Nerve Repair Pathways
Andrew S. Welleford, Jorge E. Quintero, Nader El Seblani, Eric M. Blalock, Sumedha Gunewardena, Steven M. Shapiro, Sean M. Riordan, Peter F. Huettl, Zain Guduru, John A. Stanford et al. · 2020 · Cell Transplantation
Central Nervous System Tissue Regeneration after Intracerebral Hemorrhage: The Next Frontier
Ruiyi Zhang, Mengzhou Xue, Voon Wee Yong · 2021 · Cells
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
Qualitative and quantitative re‐evaluation of epidermal growth factor‐ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target‐derived neurotrophic signaling (Part 1)
Yuriko Iwakura, Yingjun Zheng, Maria Chiara Sibilia, Yuichi Abe, Ying‐shan Piao, Daisaku Yokomaku, Ran Wang, Yuta Ishizuka, Nobuyuki Takei, Hiroyuki Nawa · 2011 · Journal of Neurochemistry
Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery
Donald P. Pizzo, Leon J. Thal · 2004 · Neuroscience
Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult
Louise Collins, Luc J. Adriaanse, Surabhi D. Theratile, Shane Vincent Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe · 2014 · Molecular Neurobiology
Utility of 6-Hydroxydopamine Lesioned Rats in the Preclinical Screening of Novel Treatments for Parkinson Disease
Maria Angela Cenci, Martin Lundblad · 2005 · Elsevier eBooks
Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors
G. Scott Ralph, Katie Binley, Liang‐Fong Wong, Mimoun Azzouz, Nicholas D. Mazarakis · 2005 · Clinical Science
Treatment of motor dysfunction in Parkinson's disease: an overview
Stéphane Thobois, Florence Delamarre-Damier, Pascal Derkinderen · 2005 · Clinical Neurology and Neurosurgery
The possible role of myelin destruction as a precipitating event in Alzheimer’s disease
Mark Noble · 2003 · Neurobiology of Aging
Neuroprotective and reparative effects of carotid body grafts in a chronic MPTP model of Parkinson's disease
Ana B. Muñoz‐Manchado, Javier Villadiego, Nela Suárez‐Luna, Alfonso Bermejo‐Navas, Pablo Garrido‐Gil, José Luis Labandeira-García, Miriam Echevarrı́a, José López‐Barneo, Juan José Toledo‐Aral · 2012 · Neurobiology of Aging
Prospects for polymer therapeutics in Parkinson's disease and other neurodegenerative disorders
Ben Newland, Heike Newland, Carsten Werner, Anne Rosser, Wenxin Wang · 2015 · Progress in Polymer Science
The use of nonhuman primate models to understand processes in Parkinson’s disease
Javier Blesa, Inés Trigo‐Damas, Natalia López‐González del Rey, Jose Angel Obeso · 2017 · Journal of Neural Transmission
Relative Patlak plot for dynamic PET parametric imaging without the need for early-time input function
Yang Zuo, Jinyi Qi, Guobao Wang · 2018 · Physics in Medicine and Biology
Natural biomaterials in brain repair: A focus on collagen
Buket Uçar · 2021 · Neurochemistry International
Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier
Anita Barzegar‐Fallah, Kushan Gandhi, Shakila B. Rizwan, Tania L. Slatter, John N. J. Reynolds · 2022 · Pharmaceutics
Neuroprotection by propargylamines in Parkinson’s disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers
Makoto Naoi, W. Maruyama, Hong Liang Yi, Yukihiro Akao, Y. Yamaoka, Masayo Shamoto‐Nagai · 2007 · Springer eBooks
GDNF in Parkinson disease: An object lesson in the tyranny of type II
Michael Hutchinson, Susan Gurney, Roger B. Newson · 2006 · Journal of Neuroscience Methods
Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole
Stefan Albrecht, Erich Buerger · 2009 · Current Medical Research and Opinion
RETRACTED ARTICLE: Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance
Md. Mominur Rahman, Md. Rezaul Islam, Fatema Akter Supti, Puja Sutro Dhar, Sheikh Shohag, Jannatul Ferdous, Shakil khan shuvo, Aklima Akter, Md. Sarowar Hossain, Rohit Sharma · 2023 · Molecular Neurobiology · Retracted
Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease
Miu Fei Lam, Meghan G. Thomas, Christopher R. P. Lind · 2011 · Journal of Clinical Neuroscience
Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action
Amit Anand, Kunio Nakamura, Jeffrey M. Spielberg, Jungwon Cha, Harish S. Karne, Bo Hu · 2020 · Translational Psychiatry
Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
Stellina Y. H. Lee, Nathanael James Yates, Susannah J. Tye · 2021 · The Neuroscientist
Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles
Haiyan Cao, Guorong Zhang, Xiaodan Wang, Lingxin Kong, Alfred I. Geller · 2008 · BMC Neuroscience
New non-oral drug delivery systems for Parkinson's disease treatment
Shadab Md, Shadabul Haque, Jasjeet Kaur Sahni, Sanjula Baboota, Javed Ali · 2011 · Expert Opinion on Drug Delivery
The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery
Ali Bienemann, E. A. White, Max Woolley, Emma S. Castrique, D. Johnson, Marcella J. Wyatt, G. Murray, Hazel Taylor, Neil U. Barua, Steven S. Gill · 2011 · Journal of Neuroscience Methods
Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses
Uta Rickert, Steffen Grampp, Henrik Wilms, Jessica Spreu, Friederike Knerlich‐Lukoschus, Janka Held‐Feindt, Ralph Lucius · 2014 · Journal of Neurodegenerative Diseases
Neuroprotection in parkinson’s disease: An elusive goal
William C. Koller, Maria Graciela Cersosimo · 2004 · Current Neurology and Neuroscience Reports
GDNF in treatment of Parkinson's disease: response to editorial
Anthony Edward Lang, J. William Langston, A. Jon Stoessl, Matthew Brodsky, David James Brooks, VIJAY M. DHAWAN, W. Jeff Elias, Andrés M. Lozano, Elena Moro, John G. Nutt et al. · 2006 · The Lancet Neurology
Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease
Tiago Martins Rodrigues, André Jerónimo-Santos, Tiago F. Outeiro, Ana Maria Sebastião, Maria José Diógenes · 2014 · Drugs & Aging
Roles for the TGFβ Superfamily in the Development and Survival of Midbrain Dopaminergic Neurons
Shane Vincent Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe · 2014 · Molecular Neurobiology
The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology
Massimo S. Fiandaca, Mitchel Stuart Berger, Krystof S. Bankiewicz · 2011 · Toxins
Update on surgery for Parkinson??s disease
Jens Volkmann · 2007 · Current Opinion in Internal Medicine
Disruption of the GDNF Binding Site in NCAM Dissociates Ligand Binding and Homophilic Cell Adhesion
Dan Sjöstrand, Jonas Carlsson, Gustavo Paratcha, Bengt Persson, Carlos F. Ibáñez · 2007 · Journal of Biological Chemistry
Combining Growth Factors, Stem Cells, and Gene Therapy for the Aging Brain
Soshana P. Behrstock, Clive Niels Svendsen · 2004 · Annals of the New York Academy of Sciences
Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma
Colin P. Sperring, Michael Argenziano, William Savage, Damian E Teasley, Pavan S. Upadhyayula, Nathan J. Winans, Peter Canoll, Jeffrey N. Bruce · 2023 · Neuro-Oncology Advances
Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat
Amjad N. Abuirmeileh, Alexander Harkavyi, Nazir Rampersaud, Rebecca Lever, John A. Tadross, Stephen Robert Bloom, Peter S. Whitton · 2012 · Journal of Pharmacy and Pharmacology
Gene Therapy for Parkinson's Disease
Rachel Denyer, Michael R. Douglas · 2012 · Parkinson s Disease
SINEUPs: a novel toolbox for RNA therapeutics
Stefano Espinoza, Carlotta Bon, Paola Valentini, Bianca Pierattini, Abraham Tettey‐Matey, Devid Damiani, Salvatore Pulcrano, Remo Sanges, Francesca Persichetti, Hazuki Takahashi et al. · 2021 · Essays in Biochemistry
Issues regarding gene therapy products for Parkinson's disease: The development of CERE-120 (AAV-NTN) as one reference point
Raymond T. Bartus, Christopher D. Herzog, Kathie M. Bishop, Jeffrey M. Ostrove, Mark H. Tuszynski, Jeffrey H. Kordower, Mehdi Gasmi · 2007 · Parkinsonism & Related Disorders
Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson’s disease models
Buket Uçar, Christian Humpel · 2019 · Brain Research Bulletin
Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
David N. Hovland, Robert B. Boyd, Mark T. Butt, Jeffery A. Engelhardt, Michael S. Moxness, Mark H. Ma, Maurice G. Emery, Nadia B. Ernst, Randall P. Reed, Jillynne R. Zeller et al. · 2007 · Toxicologic Pathology
GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson’s Disease
Shoujia Sun, Quan Zhang, Man Li, Pan Gao, Kuan Huang, Rajluxmee Beejadhursing, Wei Jiang, Ting Lei, Mingxin Zhu, Kai Shu · 2020 · Cell Transplantation
GDNF clinical trials for Parkinson’s disease: a critical human dimension
Don Marshall Gash, Greg A. Gerhardt, Luke H. Bradley, Renee P. Wagner, John T. Slevin · 2020 · Cell and Tissue Research
On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
Paulina Troncoso-Escudero, Denisse Sepúlveda, Rodrigo Pérez-Arancibia, Alejandra V. Parra, J. Arcos, Felipe Grunenwald, René L. Vidal · 2020 · Frontiers in Aging Neuroscience
Calcitriol Promotes Augmented Dopamine Release in the Lesioned Striatum of 6-Hydroxydopamine Treated Rats
Wayne A. Cass, Laura E. Peters, Anita M. Fletcher, David M. Yurek · 2014 · Neurochemical Research
Large Animal Models are Critical for Rationally Advancing Regenerative Therapies
Dustin R. Wakeman, Andrew Crain, Evan Y. Snyder · 2006 · Regenerative Medicine
Future directions in the treatment of Parkinson's disease
Anthony H.V. Schapira · 2007 · Movement Disorders
Biotechnology: Crossing the barrier
Brian Vastag · 2010 · Nature
Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases
Herzog, Christopher D., Bishop, Kathie M., Brown, Lamar, Wilson, Alistair, Kordower, Jeffrey H., Bartus, Raymond T. · 2011 · Drug Delivery and Translational Research
Neurotrophic Factors and Neurodegenerative Diseases
Barbara Ruozi, Daniela Belletti, Lucia Bondioli, Alessandro De Vita, Flavio Forni, Maria Angela Vandelli, Giovanni Tosi · 2012 · International review of neurobiology
Design of an in-dwelling cannula for convection-enhanced delivery
Kathryn Hammond Rosenbluth, Matthias Luz, Erich Mohr, Stephan Mittermeyer, John Bringas, Krystof S. Bankiewicz · 2010 · Journal of Neuroscience Methods
Regulated Expression of Lentivirus-Mediated GDNF in Human Bone Marrow-Derived Mesenchymal Stem Cells and Its Neuroprotection on Dopaminergic Cells In Vitro
Weihua Yang, Chun Yang, Yue-Qiang Xue, Tao Lu, Jakob Reiser, Li‐Ru Zhao, Wei‐Ming Duan · 2013 · PLoS ONE
Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease
Virginia Mesa-Infante, Domingo Afonso‐Oramas, Josmar Salas-Hernández, Julia Rodríguez-Núñez, Pedro Barroso‐Chinea · 2021 · Molecular and Cellular Neuroscience
Safety and Function of a New Clinical Intracerebral Microinjection Instrument for Stem Cells and Therapeutics Examined in the Göttingen Minipig
Carsten Reidies Bjarkam, Andreas Nørgaard Glud, Lee Margolin, Karl Reinhart, Ron Franklin, Dorthe Deding, Kåre Schmidt Ettrup, Lise Moberg Fitting, Mette Slot Nielsen, Jens Christian Hedemann Sørensen et al. · 2009 · Stereotactic and Functional Neurosurgery
Clearance and Toxicity of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHu GDNF) Following Acute Convection-Enhanced Delivery into the Striatum
Hannah Taylor, Neil U. Barua, Alison S. Bienemann, Marcella J. Wyatt, Emma S. Castrique, Rebecca Rachael Foster, Matthias Luz, Christian Fibiger, Erich Mohr, Steven S. Gill · 2013 · PLoS ONE
Assessment of GDNF in Primate Models of Parkinson's Disease: Comparison with Human Studies
Andisheh Eslamboli · 2005 · Reviews in the Neurosciences